Last checked at LONDON (Alliance News) - The following shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
Societe Generale Cuts Glencore Price Target To 100p From 130p, Keeps Buy
----------
EXANE BNP CUTS MARKS & SPENCER PRICE TARGET TO 580 (620) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES DIXONS CARPHONE PRICE TARGET TO 560 (510) PENCE - 'OUTPERFORM'
----------
UBS CUTS RIO TINTO PRICE TARGET TO 2600 (2700) PENCE - 'BUY'
----------
UBS CUTS ANTOFAGASTA PRICE TARGET TO 450 (510) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS RIO TINTO PRICE TARGET TO 1700 (1825) PENCE - 'SELL'
----------
GOLDMAN CUTS BHP BILLITON PRICE TARGET TO 750 (925) PENCE - 'NEUTRAL'
----------
GOLDMAN CUTS ANGLO AMERICAN PRICE TARGET TO 250 (280) PENCE - 'SELL'
----------
FTSE 250
----------
UBS INITIATES RESTAURANT GROUP WITH 'BUY' - TARGET 860 PENCE
----------
Numis Cuts Elementis Target To 253p From 271p, Keeps Add
----------
EXANE BNP CUTS ELEMENTIS PRICE TARGET TO 220 (250) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS ELEMENTIS PRICE TARGET TO 215 (255) PENCE - 'NEUTRAL'
----------
EXANE BNP CUTS N BROWN PRICE TARGET TO 260 (280) PENCE - 'UNDERPERFORM'
----------
EXANE BNP CUTS HOME RETAIL PRICE TARGET TO 80 (100) PENCE - 'UNDERPERFORM'
----------
N+1 Singer Upgrades Bodycote To Buy From Hold, Price Target At 635p
----------
UBS CUTS VEDANTA PRICE TARGET TO 330 (400) PENCE - 'NEUTRAL'
----------
UBS CUTS ACACIA MINING PRICE TARGET TO 275 (300) PENCE - 'BUY'
----------
UBS CUTS BOVIS HOMES PRICE TARGET TO 1290 (1450) PENCE - 'BUY'
----------
BARCLAYS CUTS VICTREX TO 'EQUAL WEIGHT' ('OVERWEIGHT') - TARGET 2100 (2300) PENCE
----------
BERENBERG RAISES NORTHGATE TO 'HOLD' ('SELL') - TARGET 400 (455) PENCE
----------
MAIN MARKET AND AIM
----------
Liberum Cuts PureTech Health Target To 194p From 199p, Keeps Buy
----------
Cantor Fitzgerald Cuts Bonmarche Holdings Target To 230p From 350p
----------
Cantor Fitzgerald Downgrades Bonmarche Holdings To Hold From Buy
----------
Panmure Ups Midatech Pharma Target To 476p From 417p, Keeps Buy
----------
PANMURE CUTS FENNER PRICE TARGET TO 100 (125) PENCE - 'SELL'
----------
EXANE BNP CUTS SIGNET GROUP PRICE TARGET TO 9400 (10000) PENCE - 'OUTPERFORM'
----------
EXANE BNP RAISES ASOS PRICE TARGET TO 4400 (4100) PENCE - 'OUTPERFORM'
----------
EXANE BNP CUTS IMAGINATION TECHNOLOGIES PRICE TARGET TO 95 (130) PENCE - 'UNDERPERFORM'
----------
DEUTSCHE BANK CUTS IMAGINATION TECHNOLOGIES PRICE TARGET TO 105 (215) PENCE - 'HOLD'
----------
HSBC CUTS STHREE PRICE TARGET TO 405 (425) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun
Copyright 2015 Alliance News Limited. All Rights Reserved.
29 May 2024 21:30
IN BRIEF: PureTech's Ankili to be acquired by Virtual Therapeutics
PureTech Health PLC - London-listed Biotech company headquartered in Boston - Says Tuesday that founded entity, Ankili Inc, a game developer focusing on improving mental health, will merge with Virtual Therapeutics Corp, a Boston-based digital therapeutics company. As of May 7, PureTech owned over 12.5 million of Ankili common stock.
Read more